BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38264743)

  • 1. The biological functions and related signaling pathways of SPON2.
    Zhang J; Liu G; Liu Y; Yang P; Xie J; Wei X
    Front Oncol; 2023; 13():1323744. PubMed ID: 38264743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.
    Lu H; Feng Y; Hu Y; Guo Y; Liu Y; Mao Q; Xue W
    J Cell Mol Med; 2020 Jan; 24(1):98-113. PubMed ID: 31691494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer.
    Lucarelli G; Rutigliano M; Bettocchi C; Palazzo S; Vavallo A; Galleggiante V; Trabucco S; Di Clemente D; Selvaggi FP; Battaglia M; Ditonno P
    J Urol; 2013 Dec; 190(6):2271-7. PubMed ID: 23665271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPON2 Is Upregulated through Notch Signaling Pathway and Promotes Tumor Progression in Gastric Cancer.
    Kang HG; Kim WJ; Noh MG; Chun KH; Kim SJ
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors.
    Tang J; Huang Q; Li X; Gu S
    Medicine (Baltimore); 2023 Sep; 102(37):e35122. PubMed ID: 37713832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spondin2 is a new prognostic biomarker for lung adenocarcinoma.
    Yuan X; Bian T; Liu J; Ke H; Feng J; Zhang Q; Qian L; Li X; Liu Y; Zhang J
    Oncotarget; 2017 Aug; 8(35):59324-59332. PubMed ID: 28938639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.
    Qian X; Li C; Pang B; Xue M; Wang J; Zhou J
    PLoS One; 2012; 7(5):e37225. PubMed ID: 22615945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway.
    Wu M; Kong D; Zhang Y
    Bone; 2023 Feb; 167():116630. PubMed ID: 36427776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG
    Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of spondin 2 eccentric expression in peripheral blood mononuclear cells in bronchial asthma.
    Zhou P; Xiang CX; Wei JF
    J Clin Lab Anal; 2021 Jun; 35(6):e23764. PubMed ID: 33998076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Spondin-2 Is Associated with Recurrence-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma.
    Ma HM; Yu M; Wu C; Huang HB; Li YW; Zhang P; Huang JJ; Cheng L; Feng G; Li GR
    Dis Markers; 2020; 2020():5074239. PubMed ID: 32952742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Comparison Spondin 2 Levels in Primary Glomerular Diseases.
    Kahvecioglu S; Ersoy A; Üstundag Y; Ayar Y; Gül CB; Yildiz A; Esen SA; Dogan I; Oruc A
    Saudi J Kidney Dis Transpl; 2020; 31(5):1014-1024. PubMed ID: 33229764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy.
    Kahvecioglu S; Guclu M; Ustundag Y; Gul CB; Dogan I; Dagel T; Esen B; Akturk Esen S; Celik H; Esen I
    Nephrology (Carlton); 2015 Oct; 20(10):721-726. PubMed ID: 25973958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
    Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
    J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells.
    Kuramitsu S; Masuda T; Hu Q; Tobo T; Yashiro M; Fujii A; Kitagawa A; Abe T; Otsu H; Ito S; Oki E; Mori M; Mimori K
    Cancer Genomics Proteomics; 2021; 18(4):521-529. PubMed ID: 34183385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of SPON2 inhibits the growth of triple-negative breast cancer.
    Hu X; Su C; Wei J
    Front Oncol; 2023; 13():1141417. PubMed ID: 36959811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived exosomal HOTAIRM1 regulates SPON2 in CAFs to promote progression of lung adenocarcinoma.
    Chen Z; Bian C; Huang J; Li X; Chen L; Xie X; Xia Y; Yin R; Wang J
    Discov Oncol; 2022 Sep; 13(1):92. PubMed ID: 36153414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer.
    Chandrasinghe P; Stebbing J; Warusavitarne J
    Oncogene; 2017 Mar; 36(11):1474-1475. PubMed ID: 27669439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.